Mirum Pharmaceuticals, Inc. — Form D

Mirum Pharmaceuticals, Inc. of FOSTER CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-29. The offering totals $68.5M, of which $68.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Laura BregeDirectorFoster City, CA
Lon C. CardonDirectorFoster City, CA
William C. FaireyDirectorFoster City, CA
Laurent C. FischerDirectorFoster City, CA
Michael C. GreyDirectorFoster City, CA
Patrick C. HeronDirectorFoster City, CA
Christopher PeetzDirectorFoster City, CA
Saira C. RamasastryDirectorFoster City, CA
Timothy WalbertDirectorFoster City, CA
Eric BjerkholtExecutive OfficerFoster City, CA
Christopher PeetzExecutive OfficerFoster City, CA
Peter RadovichExecutive OfficerFoster City, CA
Tiba AynechiDirectorSouth San Francisco, CA
Michael GreyDirectorSouth San Francisco, CA
Michael GreyExecutive OfficerSouth San Francisco, CA
Michael G GreyDirectorBoulder, CO
Jonathan LeffDirectorNess Ziona, L3
Susan DubeExecutive OfficerSandy, UT
Patrick HeronDirectorPhiladelphia, PA
Pamela Jonathan VigExecutive OfficerFoster City, CA
Edwin Jonathan TuckerExecutive OfficerFoster City, CA
Peter J RadovichExecutive OfficerFoster City, CA
Lara J LongpreExecutive OfficerFoster City, CA
Ian J ClementsExecutive OfficerFoster City, CA
Niall J O'DonnellDirectorFoster City, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2020-12-30D$10.0M$10.0M
2018-11-20D$120.1M$60.1M

More